{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:45:37Z","timestamp":1788245137148,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100013041","name":"Vice-Chancellor for Research, Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["27787"],"award-info":[{"award-number":["27787"]}],"id":[{"id":"10.13039\/501100013041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-26693-8","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T10:45:51Z","timestamp":1764326751000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Safety and efficacy of niosomal and conventional tranexamic acid\/niacinamide vs. hydroquinone creams in melasma: A randomized, double-blind, case-controlled clinical trial"],"prefix":"10.1038","volume":"15","author":[{"given":"Parisa","family":"Ghasemiyeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin Fazelzadeh","family":"Haghighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladan","family":"Dastgheib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ranjbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soliman","family":"Mohammadi-Samani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"26693_CR1","doi-asserted-by":"publisher","first-page":"e15143","DOI":"10.1111\/dth.15143","volume":"34","author":"MS Kumaran","year":"2021","unstructured":"Kumaran, M. S. et al. Clinico-epidemiological profile and long term follow up in melasma. Dermatol. Ther. 34, e15143 (2021).","journal-title":"Dermatol. Ther."},{"key":"26693_CR2","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1046\/j.0007-0963.2001.04556.x","volume":"146","author":"W Kang","year":"2002","unstructured":"Kang, W. et al. Melasma: histopathological characteristics in 56 Korean patients. Br. J. Dermatol. 146, 228\u2013237 (2002).","journal-title":"Br. J. Dermatol."},{"key":"26693_CR3","doi-asserted-by":"publisher","first-page":"484","DOI":"10.4103\/idoj.idoj_463_21","volume":"13","author":"M Daroach","year":"2022","unstructured":"Daroach, M., Vinay, K., Bishnoi, A., Parsad, D. & Kumaran, M. S. Extrafacial melasma: a scenario less explored. Indian Dermatology Online J. 13, 484\u2013486 (2022).","journal-title":"Indian Dermatology Online J."},{"key":"26693_CR4","doi-asserted-by":"crossref","unstructured":"Wu, M. X., Antony, R. & Mayrovitz, H. N. Melasma: a condition of Asian skin. Cureus 13, 1-9 (2021).","DOI":"10.7759\/cureus.14398"},{"key":"26693_CR5","doi-asserted-by":"publisher","first-page":"1337282","DOI":"10.3389\/fphar.2024.1337282","volume":"15","author":"P Ghasemiyeh","year":"2024","unstructured":"Ghasemiyeh, P. et al. Different therapeutic approaches in melasma: advances and limitations. Front. Pharmacol. 15, 1337282 (2024).","journal-title":"Front. Pharmacol."},{"key":"26693_CR6","first-page":"2376","volume":"1","author":"I Muller","year":"2014","unstructured":"Muller, I. & Rees, D. Melasma and endocrine disorders. Pigmentary Disorders S 1, 2376\u20130427 (2014).","journal-title":"Pigmentary Disorders S"},{"key":"26693_CR7","unstructured":"Basit, H., Godse, K. V. & Al Aboud, A. M. In StatPearls (StatPearls Publishing Copyright \u00a9 2025 (StatPearls Publishing LLC, 2025)."},{"key":"26693_CR8","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1016\/j.ddmec.2008.02.001","volume":"5","author":"M Brenner","year":"2008","unstructured":"Brenner, M. & Hearing, V. J. Modifying skin pigmentation\u2013approaches through intrinsic biochemistry and exogenous agents. Drug Discovery Today: Disease Mech. 5, e189\u2013e199 (2008).","journal-title":"Drug Discovery Today: Disease Mech."},{"key":"26693_CR9","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1111\/1346-8138.16542","volume":"49","author":"J Yang","year":"2022","unstructured":"Yang, J., Zeng, J. & Lu, J. Mechanisms of ultraviolet-induced melasma formation: A review. J. Dermatol. 49, 1201\u20131210 (2022).","journal-title":"J. Dermatol."},{"key":"26693_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.5021\/ad.23.133","volume":"36","author":"JY Jo","year":"2024","unstructured":"Jo, J. Y., Chae, S. J. & Ryu, H. J. Update on melasma treatments. Ann. Dermatol. 36, 125\u2013134. https:\/\/doi.org\/10.5021\/ad.23.133 (2024).","journal-title":"Ann. Dermatol."},{"key":"26693_CR11","doi-asserted-by":"crossref","unstructured":"Phansuk, K., Vachiramon, V., Jurairattanaporn, N., Chanprapaph, K. & Rattananukrom, T. Dermal pathology in melasma: an update review. Clinical Cosmet. Invest. Dermatology. 15, 11\u201319 (2022).","DOI":"10.2147\/CCID.S343332"},{"key":"26693_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/tjp.tjp_54_23","volume":"10","author":"P Kour","year":"2024","unstructured":"Kour, P., Soodan, P. S., Singh, M., Arora, R. & Gupta, U. Anxiety and depression among patients with melasma: A cross-sectional study. Telangana J. Psychiatry. 10, 22\u201326 (2024).","journal-title":"Telangana J. Psychiatry"},{"key":"26693_CR13","doi-asserted-by":"publisher","first-page":"324","DOI":"10.4103\/psychiatry.IndianJPsychiatry_115_16","volume":"60","author":"SS Deshpande","year":"2018","unstructured":"Deshpande, S. S., Khatu, S. S., Pardeshi, G. S. & Gokhale, N. R. Cross-sectional study of psychiatric morbidity in patients with melasma. Indian J. Psychiatry. 60, 324\u2013328 (2018).","journal-title":"Indian J. Psychiatry"},{"key":"26693_CR14","doi-asserted-by":"publisher","first-page":"1276906","DOI":"10.3389\/fpsyt.2023.1276906","volume":"14","author":"W Chen","year":"2024","unstructured":"Chen, W., Wan, Y., Sun, Y., Gao, C. & Li, J. Prevalence of depression in melasma: a systematic review and meta-analysis. Front. Psychiatry. 14, 1276906 (2024).","journal-title":"Front. Psychiatry"},{"key":"26693_CR15","doi-asserted-by":"crossref","unstructured":"Ocampo-Candiani, J. et al. Latin American consensus on the treatment of melasma.\u00a0Int. J. Dermatol.\u00a0(2024).","DOI":"10.1111\/ijd.17522"},{"key":"26693_CR16","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s12551-020-00760-y","volume":"12","author":"VG Kanellis","year":"2020","unstructured":"Kanellis, V. G. Objective quantification of melasma severity using melanometers to quantify melanin pigmentation. Biophys. Rev. 12, 1139\u20131140. https:\/\/doi.org\/10.1007\/s12551-020-00760-y (2020).","journal-title":"Biophys. Rev."},{"key":"26693_CR17","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s13555-022-00779-x","volume":"12","author":"ACC Esp\u00f3sito","year":"2022","unstructured":"Esp\u00f3sito, A. C. C. et al. Update on melasma\u2014Part I: pathogenesis. Dermatology Therapy. 12, 1967\u20131988 (2022).","journal-title":"Dermatology Therapy"},{"key":"26693_CR18","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1001\/jamadermatol.2016.1006","volume":"152","author":"M Rodrigues","year":"2016","unstructured":"Rodrigues, M., Ayala-Cort\u00e9s, A. S., Rodr\u00edguez-Ar\u00e1mbula, A., Hynan, L. S. & Pandya, A. G. Interpretability of the modified melasma area and severity index (mMASI). JAMA Dermatology. 152, 1051\u20131052 (2016).","journal-title":"JAMA Dermatology"},{"key":"26693_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/pcmr.12684","volume":"31","author":"T Passeron","year":"2018","unstructured":"Passeron, T. & Picardo, M. Melasma, a Photoaging disorder. Pigment cell. Melanoma Res. 31, 461\u2013465 (2018).","journal-title":"Pigment cell. Melanoma Res."},{"key":"26693_CR20","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s13555-022-00780-4","volume":"12","author":"DP Cassiano","year":"2022","unstructured":"Cassiano, D. P. et al. Update on Melasma\u2014part II: treatment. Dermatology Therapy. 12, 1989\u20132012 (2022).","journal-title":"Dermatology Therapy"},{"key":"26693_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0019-5154.57602","volume":"54","author":"D Bandyopadhyay","year":"2009","unstructured":"Bandyopadhyay, D. Topical treatment of melasma. Indian J. Dermatol. 54, 303\u2013309. https:\/\/doi.org\/10.4103\/0019-5154.57602 (2009).","journal-title":"Indian J. Dermatol."},{"key":"26693_CR22","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1111\/jocd.15242","volume":"21","author":"VK Mahajan","year":"2022","unstructured":"Mahajan, V. K. et al. Medical therapies for melasma. J. Cosmet. Dermatol. 21, 3707\u20133728 (2022).","journal-title":"J. Cosmet. Dermatol."},{"key":"26693_CR23","unstructured":"Melasma: Diagnosis and treatment, https:\/\/www.aad.org\/public\/diseases\/a-z\/melasma-treatment (."},{"key":"26693_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jaad.2023.07.1045","volume":"90","author":"SR Desai","year":"2024","unstructured":"Desai, S. R. et al. Best practices in the treatment of melasma with a focus on patients with skin of color. J. Am. Acad. Dermatol. 90, 269\u2013279 (2024).","journal-title":"J. Am. Acad. Dermatol."},{"key":"26693_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/der2.152","volume":"4","author":"S AlSalem","year":"2023","unstructured":"AlSalem, S. & Alexis, A. Melasma hyperpigmentation: an overview of current topical therapeutics. Dermatological Reviews. 4, 38\u201352 (2023).","journal-title":"Dermatological Reviews"},{"key":"26693_CR26","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/ced.14480","volume":"46","author":"T Searle","year":"2021","unstructured":"Searle, T., Al-Niaimi, F. & Ali, F. R. Hydroquinone: Myths and reality. Clin. Exp. Dermatol. 46, 636\u2013640. https:\/\/doi.org\/10.1111\/ced.14480 (2021).","journal-title":"Clin. Exp. Dermatol."},{"key":"26693_CR27","doi-asserted-by":"publisher","first-page":"769","DOI":"10.4103\/idoj.idoj_490_22","volume":"14","author":"R Sarkar","year":"2023","unstructured":"Sarkar, R. et al. Topical and systemic therapies in melasma: a systematic review. Indian Dermatology Online J. 14, 769\u2013781 (2023).","journal-title":"Indian Dermatology Online J."},{"key":"26693_CR28","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/ijd.13578","volume":"56","author":"LL Zhou","year":"2017","unstructured":"Zhou, L. L. & Baibergenova, A. Melasma: systematic review of the systemic treatments. Int. J. Dermatol. 56, 902\u2013908 (2017).","journal-title":"Int. J. Dermatol."},{"key":"26693_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijwd.2017.01.004","volume":"3","author":"M Trivedi","year":"2017","unstructured":"Trivedi, M., Yang, F. & Cho, B. A review of laser and light therapy in melasma. Int. J. Women\u2019s Dermatology. 3, 11\u201320 (2017).","journal-title":"Int. J. Women\u2019s Dermatology"},{"key":"26693_CR30","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/ijd.15133","volume":"60","author":"KM Babbush","year":"2021","unstructured":"Babbush, K. M., Babbush, R. A. & Khachemoune, A. Treatment of melasma: a review of less commonly used antioxidants. Int. J. Dermatol. 60, 166\u2013173 (2021).","journal-title":"Int. J. Dermatol."},{"key":"26693_CR31","first-page":"E73","volume":"12","author":"JV Wang","year":"2019","unstructured":"Wang, J. V., Jhawar, N. & Saedi, N. Tranexamic acid for melasma: evaluating the various formulations. J. Clin. Aesthet. Dermatol. 12, E73\u2013e74 (2019).","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"26693_CR32","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/ced.12835","volume":"41","author":"S Kim","year":"2016","unstructured":"Kim, S., Park, J. Y., Shibata, T., Fujiwara, R. & Kang, H. Efficacy and possible mechanisms of topical Tranexamic acid in melasma. Clin. Exp. Dermatol. 41, 480\u2013485 (2016).","journal-title":"Clin. Exp. Dermatol."},{"key":"26693_CR33","first-page":"753","volume":"19","author":"B Ebrahimi","year":"2014","unstructured":"Ebrahimi, B. & Naeini, F. F. Topical Tranexamic acid as a promising treatment for melasma. J. Res. Med. Sciences: Official J. Isfahan Univ. Med. Sci. 19, 753 (2014).","journal-title":"J. Res. Med. Sciences: Official J. Isfahan Univ. Med. Sci."},{"key":"26693_CR34","doi-asserted-by":"crossref","unstructured":"Ghasemiyeh, P. & Mohammadi-Samani, S. Potential of nanoparticles as permeation enhancers and targeted delivery options for skin: advantages and disadvantages. Drug Des. Dev. Therapy. 14, 3271\u20133289 (2020).","DOI":"10.2147\/DDDT.S264648"},{"key":"26693_CR35","doi-asserted-by":"publisher","first-page":"103595","DOI":"10.1016\/j.jddst.2022.103595","volume":"74","author":"P Ghasemiyeh","year":"2022","unstructured":"Ghasemiyeh, P. et al. Novel topical drug delivery systems in acne management: molecular mechanisms and role of targeted delivery systems for better therapeutic outcomes. J. Drug Deliv. Sci. Technol. 74, 103595 (2022).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"26693_CR36","doi-asserted-by":"crossref","unstructured":"Hizli, P., Kili\u00e7, F. A. & \u0130\u00e7\u00f6z Ayta\u00e7, S. Melasma revisited: National survey reveals how dermatologists diagnose and treat this complex skin condition. Journal Cosmet. Dermatology. 24, (2024).","DOI":"10.1111\/jocd.16630"},{"key":"26693_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2024.12419","volume":"27","author":"Y Chen","year":"2024","unstructured":"Chen, Y., Vellaichamy, G., Schneider, S. L., Kong, W. & Liu, Z. Exposure factors in the occurrence and development of melasma. Experimental Therapeutic Med. 27, 1\u20137 (2024).","journal-title":"Experimental Therapeutic Med."},{"key":"26693_CR38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s10103-024-04066-3","volume":"39","author":"H Yao","year":"2024","unstructured":"Yao, H. et al. Definition of refractory melasma and its treatment: a review. Lasers Med. Sci. 39, 118 (2024).","journal-title":"Lasers Med. Sci."},{"key":"26693_CR39","doi-asserted-by":"publisher","first-page":"366","DOI":"10.4103\/idoj.idoj_245_21","volume":"13","author":"A Navya","year":"2022","unstructured":"Navya, A. & Pai, V. Comparison of dermoscope and woods lamp as A tool to study melanin depth in melasma. Indian Dermatol. Online J. 13, 366\u2013369. https:\/\/doi.org\/10.4103\/idoj.idoj_245_21 (2022).","journal-title":"Indian Dermatol. Online J."},{"key":"26693_CR40","doi-asserted-by":"publisher","first-page":"380","DOI":"10.4103\/0019-5154.84722","volume":"56","author":"A Achar","year":"2011","unstructured":"Achar, A. & Rathi, S. K. Melasma: a clinico-epidemiological study of 312 cases. Indian J. Dermatol. 56, 380\u2013382. https:\/\/doi.org\/10.4103\/0019-5154.84722 (2011).","journal-title":"Indian J. Dermatol."},{"key":"26693_CR41","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3126\/jkmc.v11i4.53551","volume":"11","author":"E Aryal","year":"2022","unstructured":"Aryal, E., Khadka, A. & Bhattarai, S. Correlation of quality of life and severity in patients with melasma. J. Kathmandu Med. Coll. 11, 210\u2013214 (2022).","journal-title":"J. Kathmandu Med. Coll."},{"key":"26693_CR42","doi-asserted-by":"publisher","first-page":"e0262833","DOI":"10.1371\/journal.pone.0262833","volume":"17","author":"Y Zhu","year":"2022","unstructured":"Zhu, Y. et al. Evaluating the quality of life among melasma patients using the MELASQoL scale: A systematic review and meta-analysis. PLoS One. 17, e0262833 (2022).","journal-title":"PLoS One"},{"key":"26693_CR43","doi-asserted-by":"publisher","first-page":"307","DOI":"10.25259\/IJDVL_49_2021","volume":"89","author":"D Srishti","year":"2023","unstructured":"Srishti, D., Chethana, S. G., Kanthraj, G. R. & Betkerur, J. B. Point counting-serial image index: a new scoring system for melasma. Indian J. Dermatol. Venereol. Leprol. 89, 307\u2013309 (2023).","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"26693_CR44","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1111\/jocd.16257","volume":"23","author":"Z Xu","year":"2024","unstructured":"Xu, Z., Wang, C., Xing, X., Zhang, C. & Xiang, L. F. Efficacy and safety of the combination of oral Tranexamic acid and intense pulsed light versus oral Tranexamic acid alone in the treatment of refractory riehl\u2019s melanosis: A prospective, comparative study. J. Cosmet. Dermatol. 23, 2049\u20132057 (2024).","journal-title":"J. Cosmet. Dermatol."},{"key":"26693_CR45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000518826","volume":"35","author":"PP Naik","year":"2022","unstructured":"Naik, P. P. & Farrukh, S. N. Influence of ethnicities and skin color variations in different populations: a review. Skin Pharmacol. Physiol. 35, 65\u201376 (2022).","journal-title":"Skin Pharmacol. Physiol."},{"key":"26693_CR46","unstructured":"Simsamer, P. & Paichitrojjana, A. A comparative study for clinical effectiveness and tolerability between 1,064 Nm picosecond laser toning combined with 4% niacinamide cream versus 4% niacinamide cream alone in the treatment of melasma in Thai patients."},{"key":"26693_CR47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3109\/14764172.2012.685478","volume":"14","author":"KN Ayuthaya","year":"2012","unstructured":"Ayuthaya, K. N., Niumphradit, P., Manosroi, N., Nakakes, A. & A. & Topical 5% Tranexamic acid for the treatment of melasma in asians: a double-blind randomized controlled clinical trial. J. Cosmet. Laser Therapy. 14, 150\u2013154 (2012).","journal-title":"J. Cosmet. Laser Therapy"},{"key":"26693_CR48","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/jcpt.13430","volume":"46","author":"X Feng","year":"2021","unstructured":"Feng, X., Su, H. & Xie, J. Efficacy and safety of Tranexamic acid in the treatment of adult melasma: an updated meta-analysis of randomized controlled trials. J. Clin. Pharm. Ther. 46, 1263\u20131273 (2021).","journal-title":"J. Clin. Pharm. Ther."},{"key":"26693_CR49","unstructured":"Irfanti, R. T., Mawardi, P. & Mulianto, N. Effectiveness of Combination TranexamicAcid 3% and Nicotinamide 3% with Microneedling in the Treatment of Melasma."},{"key":"26693_CR50","doi-asserted-by":"crossref","unstructured":"Barbosa, M. et al. Efficacy and safety of nicotinamide 10%, associated with magnesium ascorbyl phosphate 5% and hyaluronic acid 5%, compared to hydroquinone 4% in women with facial melasma: A Randomized, Double-Blind, controlled clinical trial. Clinical Cosmet. Invest. Dermatology. 17, 2215\u20132223 (2024).","DOI":"10.2147\/CCID.S473224"},{"key":"26693_CR51","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/jocd.12987","volume":"19","author":"M Gheisari","year":"2020","unstructured":"Gheisari, M. et al. The efficacy and safety of topical 5% methimazole vs 4% hydroquinone in the treatment of melasma: A randomized controlled trial. J. Cosmet. Dermatol. 19, 167\u2013172 (2020).","journal-title":"J. Cosmet. Dermatol."},{"key":"26693_CR52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/jocd.12291","volume":"16","author":"V Lajevardi","year":"2017","unstructured":"Lajevardi, V. et al. Comparison of the therapeutic efficacy and safety of combined oral Tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor\u2010and analyst\u2010blinded, randomized controlled trial with a short\u2010term follow\u2010up. J. Cosmet. Dermatol. 16, 235\u2013242 (2017).","journal-title":"J. Cosmet. Dermatol."},{"key":"26693_CR53","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/jocd.12769","volume":"18","author":"A Nofal","year":"2019","unstructured":"Nofal, A., Ibrahim, A. S. M., Nofal, E., Gamal, N. & Osman, S. Topical Silymarin versus hydroquinone in the treatment of melasma: A comparative study. J. Cosmet. Dermatol. 18, 263\u2013270 (2019).","journal-title":"J. Cosmet. Dermatol."},{"key":"26693_CR54","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s13555-017-0195-0","volume":"7","author":"N Atefi","year":"2017","unstructured":"Atefi, N., Dalvand, B., Ghassemi, M., Mehran, G. & Heydarian, A. Therapeutic effects of topical Tranexamic acid in comparison with hydroquinone in treatment of women with melasma. Dermatology Therapy. 7, 417\u2013424 (2017).","journal-title":"Dermatology Therapy"},{"key":"26693_CR55","doi-asserted-by":"crossref","unstructured":"Sarkar, R., Bansal, S. & Sethi, S. Hydroquinone based therapies for melasma. Melasma: Monograph. 8, 35\u201340 (2015).","DOI":"10.5005\/jp\/books\/12401_9"},{"key":"26693_CR56","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/cosmetics9060127","volume":"9","author":"SM Mawazi","year":"2022","unstructured":"Mawazi, S. M., Ann, T. J. & Widodo, R. T. Application of niosomes in cosmetics: a systematic review. Cosmetics 9, 127 (2022).","journal-title":"Cosmetics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26693-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26693-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26693-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T10:45:54Z","timestamp":1764326754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26693-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["26693"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-26693-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed according to the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Shiraz University of Medical Sciences [Ethics Approval ID: IR.SUMS.REC.1402.050] and Iranian Registry of Clinical Trials (IRCT) [IRCT Approval ID: IRCT20220609055116N1, approval date: 07\/23\/2023]. The full clinical trial protocol can be find through\n                      \n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Informed consent was obtained from all participants and\/or their legal guardians.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent was obtained from all participants to publish the information\/images in an online open access publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"42739"}}